Apollo Endosurgery, Inc.
(NASDAQ : APEN)

( )
APEN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.95%582.821.0%$844.15m
DHRDanaher Corp. 0.26%301.200.7%$674.24m
ABTAbbott Laboratories -0.09%117.460.8%$620.40m
MDTMedtronic Plc 2.32%127.700.6%$526.13m
ALGNAlign Technology, Inc. -1.36%589.616.3%$337.47m
BDXBecton, Dickinson & Co. -0.61%241.201.0%$335.40m
ISRGIntuitive Surgical, Inc. 0.17%331.500.8%$317.01m
SYKStryker Corp. 0.96%266.381.3%$284.16m
DXCMDexCom, Inc. -1.81%544.477.8%$282.68m
IDXXIDEXX Laboratories, Inc. 0.86%635.153.8%$276.25m
EWEdwards Lifesciences Corp. 0.59%112.230.4%$260.36m
BSXBoston Scientific Corp. 0.44%43.441.0%$256.50m
AAgilent Technologies, Inc. 0.54%153.421.6%$222.45m
BAXBaxter International, Inc. -0.26%79.681.8%$200.18m
ZBHZimmer Biomet Holdings, Inc. 0.81%146.811.7%$174.98m

Company Profile

Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, OverStitch Sx Endoscopic Suturing System, and Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas; inadvertent perforation of the GI tract; tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon; the treatment of swallowing disorders; esophageal stent fixation and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.